MCB
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
MCB Accepts, published online ahead of print on 11 February 2008
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
MCB.01795-07v1
28/8/2579    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Kim, K.-Y.
Right arrow Articles by Levin, D. E.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, K.-Y.
Right arrow Articles by Levin, D. E.
Mol. Cell. Biol. doi:10.1128/MCB.01795-07
Copyright (c) 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Yeast Mpk1 MAPK activates transcription through Swi4/Swi6 by a non-catalytic mechanism that requires upstream signal

Ki-Young Kim, Andrew W. Truman, and David E. Levin*

Department of Biochemistry & Molecular Biology, Bloomberg School of Public Health, The Johns Hopkins University, Baltimore, Maryland 21205

* To whom correspondence should be addressed. Email: levin{at}jhmi.edu.


   Abstract

The cell wall integrity MAPK cascade of Saccharomyces cerevisiae drives changes in gene expression in response to cell wall stress. We show that the MAPK of this pathway (Mpk1) and its pseudokinase paralog (Mlp1) use a non-catalytic mechanism to activate transcription of the FKS2 gene. Transcriptional activation of FKS2 was dependent on the Swi4/Swi6 (SBF) transcription factor and on an activating signal to Mpk1, but not on protein kinase activity. Activated (phosphorylated) Mpk1 and Mlp1 were detected in a complex with Swi4 and Swi6 at the FKS2 promoter. Mpk1 association with Swi4 in vivo required phosphorylation of Mpk1. Promoter association of Mpk1 and the Swi4 DNA-binding subunit of SBF were co-dependent, but did not require Swi6, indicating that the MAPK confers DNA-binding ability to Swi4. Based on these data, we propose a model in which phosphorylated Mpk1 or Mlp1 form a dimeric complex with Swi4 that is competent to associate with the FKS2 promoter. This complex then recruits Swi6 to activate transcription. Finally, we show that human ERK5, a functional ortholog of Mpk1, is similarly capable of driving FKS2 expression in the absence of protein kinase activity, suggesting that this mammalian MAPK may also have a non-catalytic function in vivo.







Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2008 by the American Society for Microbiology. All rights reserved.